It's a histamine H1 antagonist used in antiallergic drugs, mainly to treat allergic rhinitis, urticaria, dermatitis, drug rash, pruritus, neurodermatitis, insect bites, solar dermatitis and influenza. It 's been used in veterinary applications as well.
This report contains market size and forecasts of Chlorphenamine in global, including the following market information:
Global Chlorphenamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chlorphenamine Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Chlorphenamine companies in 2021 (%)
The global Chlorphenamine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chlorphenamine include Bayer Healthcare Llc., GlaxoSmithKline, Merck, UCB, Mylan, Rugby Laboratories Inc., A&Z Pharmaceutical, Inc. and Henan Jiushi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chlorphenamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chlorphenamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Chlorphenamine Market Segment Percentages, by Type, 2021 (%)
Tablet
Syrup
Solution
Global Chlorphenamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Chlorphenamine Market Segment Percentages, by Application, 2021 (%)
Injection
Oral
External Use
Global Chlorphenamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Chlorphenamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chlorphenamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chlorphenamine revenues share in global market, 2021 (%)
Key companies Chlorphenamine sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Chlorphenamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare Llc.
GlaxoSmithKline
Merck
UCB
Mylan
Rugby Laboratories Inc.
A&Z Pharmaceutical, Inc.
Henan Jiushi